pharmaphorum

DECEMBER 30, 2021

Johnson & Johnson’s much-touted crop of bispecific antibodies for cancer generated its first commercial product in May, and the drugmaker has now filed for FDA approval of a second candidate. The latest to reach the regulatory stage is teclistamab, one of two bispecifics for multiple myeloma in the late-stage pipeline of J&J’s Janssen division stemming from its longstanding and fertile collaboration with Danish biotech Genmab.

FDA 122

FDA Chemotherapy Immunization 122

The Physician Pharmacist

DECEMBER 30, 2021

Whether you've finished the medical school application cycle or are just curious about the economics of medical school, the answer to our question is obviously yes ! You undoubtedly worked as a pharmacy intern during school, so I am confident that you can easily work as a higher paying pharmacist. It's apparent that your role in the pharmacy will change and you will have expanded responsibilities, but you have been training for this moment for 4 years.

Medical Schools 52

Medical Schools Community Pharmacies Specialty Pharmacies Compounding 52